Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

NCT06181292 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

913

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV2 Infection

Interventions

BIOLOGICAL: PHH-1V81
BIOLOGICAL: Comirnaty Omicron XBB1.5

Sponsor

Hipra Scientific, S.L.U